This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Synchron Systems Salicylate Reagent
- Starting date:
- June 22, 2017
- Posting date:
- July 17, 2017
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-63990
Reason
Beckman Coulter has identified Temozolomide, an oral antineoplastic drug used to treat certain types of brain cancers, as a potential source of interference with Synchron salicylate reagent. Patients treated with Temozolomide may generate a false low result for salicylate.
Affected products
Synchron Systems Salicylate Reagent
Lot or serial number
All lots
Model or catalog number
378194
Companies
- Manufacturer
-
Beckman Coulter Inc.
250 S. Kraemer Blvd.
Brea
92821
UNITED STATES